Studying infectious diseases is vitally important if insurers and reinsurers are to avoid getting caught out by the next outbreak of something like the Zika virus, the mosquito-borne virus linked to birth defects, according to epidemic risk modelling company Metabiota.
The company has been working with re/insurers to help them better understand the risks involved in widespread flu outbreaks, as well as any other virulent infectious disease.
Metabiota has been collaborating with Munich Re in particular in recent years, giving the reinsurer access to its epidemiological database that allows the reinsurer to create novel insurance products or simply improve capital utilisation and enterprise risk management.
“The collaboration began almost four years ago on the back of Metabiota’s history and commitment to delivering an innovative platform for monitoring and analysing epidemic risk,” said Megan Stewart Hodge, global head of business development, Metabiota.
[...]